News
Formalize Raises €30M Series B to Scale Compliance Platform
Copenhagen’s Formalize secures €30M Series B funding from Acton Capital and Blackfin Tech to expand compliance automation across Europe.
MoleSense Secures €156K for Molecular Maternity Wearables
MoleSense secures €156,000 in maternity wearables funding from Venture Kick to bring molecular monitoring to high-risk pregnancies across Europe.
SpinDrive Secures Magnetic Bearing Funding for US Push
Finland’s SpinDrive lands new growth funding from Rhapsody Venture Partners and Innovestor to scale magnetic bearing tech and launch Magma X100 across US markets.
Sequoia Launches €874M Europe Venture Funds
Sequoia unveils €874M across two Europe venture funds, with partner Luciana Lixandru declaring Europe’s founder pool “never been stronger” amid AI boom.
Steven.com raises €46M in media tech funding breakthrough
The European media technology sector is witnessing a remarkable transformation as traditional entertainment boundaries blur with digital innovation. In this evolving landscape, Steven.com has secured €46 million in funding, marking…
The hidden costs of events: Why founders get the math wrong
Most startup founders treat events like they’re going travelling: count the days, block the calendar, done. But event tickets don’t come cheap, and the actual affair can eat into your…
Dracula Technologies raises €30M Series A for ambient energy
The ambient energy harvesting sector is experiencing unprecedented momentum across Europe as industries seek sustainable alternatives to traditional battery systems. French innovator Dracula Technologies has captured €30 million in its…
Cellcolabs raises €10.3M for stem cell manufacturing innovation
Europe’s biotechnology sector is witnessing unprecedented investment in manufacturing innovation, with Swedish companies leading the charge in making advanced therapies accessible worldwide. The latest milestone comes from Cellcolabs, which has…
Adaptam Therapeutics raises €3M in cancer immunotherapy funding
Europe’s oncology sector is witnessing a surge in innovative approaches to tackle cancer’s most persistent challenge: immune evasion. While traditional immunotherapies have shown promise, tumours continue to develop sophisticated mechanisms…
Lithea Raises €851K for Childhood Bone Cancer Treatment
Childhood bone cancer represents one of oncology’s most challenging frontiers, where traditional treatments often fall short and innovative approaches struggle to secure adequate funding. The European biotech landscape has witnessed…